Ventana Biotech, Inc.

VNTA · OTC
Analyze with AI
12/31/2024
12/31/2023
12/31/2021
12/31/2019
Assets
Cash & Equivalents$62$34
Short-Term Investments$0$0
Receivables$0$0
Inventory$0$0
Other Curr. Assets$0$0
Total Curr. Assets$62$34
Property Plant & Equip (Net)$0$0
Goodwill$0$0
Intangibles$0$0
Long-Term Investments$0$0
Tax Assets$0$0
Other NC Assets$0$0
Total NC Assets$0$0
Other Assets$0$0
Total Assets$62$34
Liabilities
Payables$4$0
Short-Term Debt$110$105
Tax Payable$0$0
Deferred Revenue$0$0
Other Curr. Liab.$1$1
Total Curr. Liab.$114$106
LT Debt$0$0
Deferred Rev, NC$0$0
Deferred Tax Liab, NC$0$0
Other NC Liab.$0$0
Total NC Liab.$0$0
Other Liabilities$0$0
Cap. Leases$0$0
Total Liabilities$114$106
Equity
Pref Stock$0$0
Common Stock$108$108
Retained Earnings-$234-$254
AOCI$0$0
Other Equity$75$75
Total Equity-$52-$72
Supplemental Information
Minority Interest$0$0
Total Liab. & Tot. Equity$62$34
Net Debt$48$71$0$0
Ventana Biotech, Inc. (VNTA) Financial Statements & Key Stats | AlphaPilot